Attana biosensors provides a reliable, fast and versatile label-free method to study molecular interactions.

Automated microscopy and image analysis
Real-time, label free cell analysis
Nano and micro particle analysis

Accelerate to discover
Related topics
Extracellular Vesicle Purity Enhanced by Gen 2 qEV Columns With Customised Proprietary Resin
May 4, 2022
Izon Science has announced the launch of Gen 2, the enhanced range of qEV columns for size-exclusion...
Multi-modal PET drives interdisciplinary preclinical imaging
Feb 23, 2022
Preclinical imaging (PCI) plays a vital role in understanding the biological processes behind disease states at the...
Quantitative 3D Optical Imaging for Lago
Feb 21, 2022
Spectral Instrument Imaging just announced a new, strategic partnership with InVivo Analytics, which enables...
Reduces fMRI-BOLD Response in the Brain
Feb 18, 2022
fMRI studies often involve the electrical stimulation of i.e. the forepaw, detecting where this stimulation is...
Extensive assessment of Cytokine production on the NovoCyte Penteon flow cytometer
Nov 23, 2021
Cytokines are small molecules essential for immune cell response to activation by pathogens, autoimmunity, or...
Oct 20, 2021
Ionizing radiation approaches are effective but use of radioactive radioisotopic elements have become difficult to...
Duke uses XRAD 225 CX to test radiosensitivity hypothesis
Oct 18, 2021
Image guided radiotherapy in a preclinical setting couldn’t be more useful than the treatment of brain tumors, where...
See What's Possible with the PippinHT
Sep 14, 2021
Programmable DNA size selection enables new discoveries by helping optimize the library detected by a sequencer. That’s...
Jun 14, 2016
The team of Professor Dr. Roland Kontermann at the Institute of Cell Biology and Immunology, University of Stuttgart, Germany has recently published an article in PLOS ONE titled A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties.
Professor Kontermann's group is working on the development of novel strategies for tumor therapy. The strategies are based on the use of specific ligands to target potent cytotoxic effector mechanism to the tumor. Their focus is on three effector arms: 1) bispecific antibodies for the retargeting of effector cells of the immune system (immunotherapy), 2) targeted carrier systems (liposomes, polymers) for drug delivery (chemotherapy), and 3) targeted cytotoxic fusion proteins (biotherapy). Main targets are molecules associated with the tumor vasculature (vascular targeting), since these structures are easily accessible for circulating agents and all solid tumors are dependent on vascularisation.
In this publication the group employed their Attana A200 system for affinity determination.
Related technologies: Label-free protein analysis
Brand profile
Attana biosensors provides a reliable, fast and versatile label-free method to study molecular interactions.
More info at:
www.attana.com/